A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion

BACKGROUND: The selective MAO-B inhibitor selegiline has been evaluated in clinical trials as a potential medication for the treatment of cocaine dependence. This study evaluated the safety of and pharmacologic interactions between 7 days of transdermal selegiline dosed with patches (Selegiline Tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Debra S, Everhart, Thomas, Jacob, Peyton, Lin, Emil, Mendelson, John E, Jones, Reese T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731040/
https://www.ncbi.nlm.nih.gov/pubmed/19646280
http://dx.doi.org/10.1186/1472-6904-9-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731040/
https://www.ncbi.nlm.nih.gov/pubmed/19646280
http://dx.doi.org/10.1186/1472-6904-9-13

Ejemplares similares